newsfilter
← Latest News
Business Wire·

Intersect ENT Announces Preliminary Revenue for Third Quarter of 2020

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced preliminary third quarter 2020 revenue and provided a business update.